Arthur Przybyl, President and CEO at ANI PHARMACEUTICALS INC (ANIP), sold 40,000 shares at $62.03 ($2.5M) on 2018-03-14, disclosed to the SEC on 2018-03-14.
Open-market sale of $2.5M ANIP by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $61.52 | 23,475 | $1.4M | 58.4% |
| 2 | $62.63 | 6,525 | $409K | 16.5% |
| 3 | $62.03 | 10,000 | $620K | 25.1% |
| Total | $61.83 avg | 40,000 | $2.5M | 100% |
| Filing → |
| ANIP | SELL | 2016-08-23 | $2.5M | — | Filing → |